UNSPSC 51102812: Allantoin/aminacrine/sulfanilamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GU300. This VA Drug Class (GU300) classifies this compound as belonging to the group ANTI-INFECTIVES, VAGINAL.

UNSPSC 51102812 Allantoin/aminacrine/sulfanilamide is a Commodity code that state and local governments nominally reference for topical antimicrobial and wound-care pharmaceuticals, though recent solicitations tagged under this code show little alignment with the code's stated scope. The most prominent recent opportunity under this code is a Seminole County, Florida naloxone and drug deactivation systems procurement—a public health and emergency response product line distinct from the code's nominal pharmaceutical antiseptics and topical agents. Issuing bodies accessing this code include county health departments and fire rescue divisions pursuing emergency medical supplies and pharmaceutical products through competitive sealed bids and cooperative purchasing vehicles. The geographic activity shown is scattered across Florida, Texas, and Minnesota, with no single jurisdiction emerging as a repeat buyer in the recent record.

The Seminole County opportunity (IFB 60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 drug deactivation systems annually through competitive bidding with a two-year initial term and one-year renewal option, with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa's medical and first aid supplies bid (26P00145, due March 13, 2026) for the Tampa Fire Department Rescue Division encompassed 169 line items of emergency medical supplies including respiratory equipment and cardiac monitoring consumables, with an estimated contract value of $700,000 and a sheltered market set-aside for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, requiring compliance with cGMP and DSCSA standards and distribution through authorized wholesalers including AmerisourceBergen Drug Corporation and Cardinal Health. The code shows limited recent activity directly aligned with its stated pharmaceutical antimicrobial scope; procurement professionals evaluating this code should verify whether opportunities are being misclassified or whether state and local agencies have absorbed topical antimicrobial procurement into broader medical supplies contracts elsewhere in the taxonomy.